Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?
about
Dopamine mercapturate can augment dopaminergic neurodegeneration.Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonismUnique responses to mitochondrial complex I inhibition in tuberoinfundibular dopamine neurons may impart resistance to toxic insult.Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.Role of activity-dependent mechanisms in the control of dopaminergic neuron survival.Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafishCalpain-mediated signaling mechanisms in neuronal injury and neurodegenerationImmunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.Role of calpain in apoptosis.Iron and dopamine: a toxic couple.Use of genetically engineered mice as models for understanding human neurodegenerative disease.Temperature-induced reversible conformational change in the first 100 residues of alpha-synuclein.Glutamyl cysteine synthetase catalytic and regulatory subunits localize to dopaminergic nigral neurons as well as to astrocytes.Activation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cells.
P2860
Q34119168-64721E20-D958-4A55-B558-EA7AFC03B063Q35455565-0755F380-6F25-4926-9FD5-5A3A6F8676CFQ36083459-71EADE05-5D7A-4E1C-99D8-EA850043E102Q36372732-E851692B-BDD5-41E0-A042-AB83435CBA17Q36777897-D58ACA30-6A72-4D13-8BF1-417C451C790BQ36808288-D038D6A4-5A3E-4E04-883F-8A91E81F674BQ37237452-712C235D-CBC7-4DC5-BD8C-0655E593DED0Q37671552-9A3E53DC-87A8-4A6F-A658-48CCEE1BE780Q38090928-653F8CAE-9010-44ED-8C8B-0F9A340BAD91Q38768061-52A5C514-695A-41D7-BB70-ED51803268BBQ40994008-527036EC-7084-4F2F-8CC5-6618EEC28EEEQ43054520-EDA4065D-4D05-4E2B-8E78-D191884360BDQ43565738-6D7833AD-4ADA-46E3-8B74-77D0EA92F687Q43572866-19AE7399-A6D1-4B77-887F-EFD39C588387
P2860
Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Why are nigral catecholaminerg ...... cells in Parkinson's disease?
@ast
Why are nigral catecholaminerg ...... cells in Parkinson's disease?
@en
type
label
Why are nigral catecholaminerg ...... cells in Parkinson's disease?
@ast
Why are nigral catecholaminerg ...... cells in Parkinson's disease?
@en
prefLabel
Why are nigral catecholaminerg ...... cells in Parkinson's disease?
@ast
Why are nigral catecholaminerg ...... cells in Parkinson's disease?
@en
P356
P1433
P1476
Why are nigral catecholaminerg ...... cells in Parkinson's disease?
@en
P2093
P2860
P304
P356
10.1002/ANA.410320715
P478
P577
1992-01-01T00:00:00Z